SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: Development and optimization

International Journal of Pharmaceutics

Volumn 391, Issue 1-2, 2010, Pages 203-211

  Basalious, Emad B ^a   Shawky, Nevine ^a   Badr Eldin, Shaimaa M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Bioenhancers; D optimal mixture design; Dissolution; Lacidipine; SNEDDS; Ternary phase diagram

Indexed keywords

BIOSURFACTANT; CAPMUL MCM C8; CREMOPHOR; DIETHYLENE GLYCOL MONOETHYL ETHER; EMULSIFYING AGENT; GLYCERYL MONOLINOLEATE; LABRAFIL M 2125 CS; LABRASOL; LACIDIPINE; LAUROGLYCOL 90; LINOLEOYL MACROGOLGLYCERIDES; MAISINE 35 1; MIGLYOL; OCTANOIN; OLEOYL MACROGOLGLYCERIDES; PEGLICOL 5 OLEATE; POLYSORBATE 80; PROPYLENE GLYCOL MONOLAURATE; TRANSCUTOL P; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG FORMULATION; DRUG MIXTURE; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; EXPERIMENTAL DESIGN; LIGHT ABSORPTION; NANOEMULSION; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; STORAGE TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY;

ADMINISTRATION, ORAL; CHEMISTRY, PHARMACEUTICAL; DIHYDROPYRIDINES; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; EMULSIONS; LIPIDS; NANOTECHNOLOGY; PARTICLE SIZE; SOLUBILITY; SURFACE-ACTIVE AGENTS;

EID: 77952887062     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.03.008     Document Type: Article

References (35)

1. Balakrishnan P., Lee B.J., Oh D.H., Kim J.O., Hong M.J., Jee J.P., Kim J.A., Yoo B.K., Woo J.S., Yong C.S., Choi H.G. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system (SEDDS). Eur. J. Pharm. Biopharm. 2009, 72:539-545.
2. Buggins T.R., Dickinson P.A., Taylor G. The effects of pharmaceutical excipients on drug disposition. Adv. Drug Deliv. Rev. 2007, 59:1482-1503.
3. Chen M.L. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv. Drug Deliv. Rev. 2008, 60:768-777.
4. Date A.A., Nagarsenker M.S. Design and evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int. J. Pharm. 2007, 329:166-172.
5. De Filippis P., Bovina E., Da Ros L., Fiori J., Cavrini V. Photodegradation studies on lacidipine in solution: basic experiments with a cis-trans reversible photoequilibrium under UV-A radiation exposure. J. Pharm. Biomed. Anal. 2002, 27:803-812.
6. Elnaggar Y.S., El-Massik M.A., Abdallah O.Y. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int. J. Pharm. 2009, 380:133-141.
7. Gao P., Witt M.J., Haskell R.J., Zamora K.M., Shifflett J.R. Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load. Pharm. Dev. Technol. 2004, 9:301-309.
8. Holm R., Jensen I.H., Sonnergaard J. Optimization of self-microemulsifying drug delivery systems (SMEDDS) using a D-optimal design and the desirability function. Drug Dev. Ind. Pharm. 2006, 32:1025-1032.
9. Hong J.Y., Kim J.K., Song Y.K., Park J.S., Kim C.K. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J. Control Release 2006, 110:332-338.
10. Huang Y.B., Tsai Y.H., Lee S.H., Chang J.S., Wu P.C. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. Int. J. Pharm. 2005, 289:87-95.
11. Huang Y.B., Tsai Y.H., Yang W.C., Chang J.S., Wu P.C., Takayama K. Once-daily propranolol extended-release tablet dosage form: formulation design and in vitro/in vivo investigation. Eur. J. Pharm. Biopharm. 2004, 58:607-614.
12. Koga K., Kawashima S., Murakami M. In vitro and in situ evidence for the contribution of Labrasol and Gelucire 44/14 on transport of cephalexin and cefoperazone by rat intestine. Eur. J. Pharm. Biopharm. 2002, 54:311-318.
13. Kommuru T.R., Gurley B., Khan M.A., Reddy I.K. Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment. Int. J. Pharm. 2001, 212:233-246.
14. Lee C.R., Bryson H.M. Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension. Drugs 1994, 48:274-296.
15. Lia P., Ghosha A., Wagnera R.F., Krillb S., Joshia Y.M., Serajuddin A.T.M. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions. Int. J. Pharm. 2005, 288:27-34.
16. Liu Y., Zhang P., Feng N., Zhang X., Wu S., Zhao J. Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin. Int. J. Pharm. 2009, 365:136-142.
17. McCormack P.L., Wagstaff A.J. Lacidipine: a review of its use in the management of hypertension. Drugs 2003, 63:2327-2356.
18. Mou D., Chen H., Du D., Mao C., Wan J., Xu H., Yang X. Hydrogel-thickened nanoemulsion system for topical delivery of lipophilic drugs. Int. J. Pharm. 2008, 353:270-276.
19. Porter C.J., Charman W.N. Intestinal lymphatic drug transport: an update. Adv. Drug Deliv. Rev. 2001, 50:61-80.
20. Porter C.J., Pouton C.W., Cuine J.F., Charman W.N. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv. Drug Deliv. Rev. 2008, 60:673-691.
21. Pouton C.W. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur. J. Pharm. Sci. 2006, 29:278-287.
22. Pouton C.W. Properties and uses of common formulation lipids, surfactants and cosolvents. AAPS Workshop 2007, http://www.aapspharmaceutica.com/meetings/files/85/03poultona.pdf.
23. Prasad Y.V., Puthli S.P., Eaimtrakarn S., Ishida M., Yoshikawa Y., Shibata N., Takada K. Enhanced intestinal absorption of vancomycin with Labrasol and d-alpha-tocopheryl PEG 1000 succinate in rats. Int. J. Pharm. 2003, 250:181-190.
24. Rane S.S., Anderson B.D. What determines drug solubility in lipid vehicles: is it predictable?. Adv. Drug Deliv. Rev. 2008, 60:638-656.
25. Rao S.V., Shao J. Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of protein drugs: I. Formulation development. Int. J. Pharm. 2008, 362:2-9.
26. Shen H., Zhong M. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. J. Pharm. Pharmacol. 2006, 58:1183-1191.
27. Subramanian N., Ray S., Ghosal S.K., Bhadra R., Moulik S.P. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol. Pharm. Bull. 2004, 27:1993-1999.
28. Taha E.I., Al-Saidan S., Samy A.M., Khan M.A. Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate. Int. J. Pharm. 2004, 285:109-119.
29. Tang J., Zhu R., Zhao R., Cheng G., Peng W. Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of lacidipine in human plasma and its application in a pharmacokinetic study. J. Pharm. Biomed. Anal. 2008, 47:923-928.
30. Wang Z., Sun J., Wang Y., Liu X., Liu Y., Fu Q., Meng P., He Z. Solid self-emulsifying nitrendipine pellets: preparation and in vitro/in vivo evaluation. Int. J. Pharm. 2010, 383:1-6.
31. Wasan E.K., Bartlett K., Gershkovich P., Sivak O., Banno B., Wong Z., Gagnon J., Gates B., Leon C.G., Wasan K.M. Development and characterization of oral lipid-based Amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans. Int. J. Pharm. 2009, 372:76-84.
32. Wei L., Sun P., Nie S., Pan W. Preparation and evaluation of SEDDS and SMEDDS containing carvedilol. Drug Dev. Ind. Pharm. 2005, 31:785-794.
33. Yu L., Bridgers A., Polli J., Vickers A., Long S., Roy A., Winnike R., Coffin M. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm. Res. 1999, 16:1812-1817.
34. Zhang H., Yao M., Morrison R.A., Chong S. Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats. Arch. Pharm. Res. 2003, 26:768-772.
35. Zhang P., Liu Y., Feng N., Xu J. Preparation and evaluation of self-microemulsifying drug delivery system of oridonin. Int. J. Pharm. 2008, 355:269-276.